前沿论文｜CELL INTELLIGENCE

Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells.

PubMed 2026/08/04 发表Front ImmunolQ1 · IF 7（JCR 2025）

Immunotherapy for pediatric solid tumors: overcoming biological barriers through rational multimodal combinations.

PubMed 2026/04/15 发表Cancer Immunol ImmunotherQ1 · IF 5.8（JCR 2025）

Decoding the immune microenvironment: precision immunotherapy for medulloblastoma subtypes.

PubMed 2026/04/13 发表Front ImmunolQ1 · IF 7（JCR 2025）

Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy.

PubMed 2026/04/02 发表Exp Hematol OncolQ1 · IF 17.5（JCR 2025）

Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma.

PubMed 2025/10/14 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

MG1 能够直接杀死 EWS 细胞并刺激 NK 细胞对该肿瘤的细胞毒性，这表明 MG1 可能为常规治疗疗效目前有限的 EWS 患者提供治疗获益。

Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcoma.

PubMed 2025/05/22 发表bioRxiv

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma.

PubMed 2024/12/21 发表Mol Ther OncolQ1 · IF 8.5（JCR 2025）

Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastoma.

PubMed 2024/09/05 发表Cancer Immunol ImmunotherQ1 · IF 5.8（JCR 2025）

据我们所知，这些研究首次证明溶瘤病毒联合自我维持的 NK 细胞在神经母细胞瘤中的作用，以及神经母细胞瘤对 NK 细胞的启动效应。

Immune cell landscape and immunotherapy of medulloblastoma.

PubMed 2021/06/21 发表Pediatr InvestigQ2 · IF 2（JCR 2025）

前沿论文 9